how is hims still selling compounded semaglutide review Hims & Hers stock crashes after FDA announces plans to take "decisive steps" against GLP-1 compounds Hims & Hers stock falls
Description
Fujita K, Matsuda K, Sakai Y, Sakai H, Mizuno K
Most GLP-1 prescriptions are written by primary care physicians, endocrinologists, and telehealth providers who may have limited training in eating disorder identification
Additionally, they inhibit the secretion of glucagon, a hormone that raises blood sugar levels, and slow gastric emptying, leading to a prolonged feeling of fullness and reduced appetite
Read the study (Hurtado et al., Menopause 2024): A 2025 review by Ushanova and Demidova in Womens Health and Reproduction reached the same conclusion
